Gamma Biologicals Inc., Immucor deal

GBL shareholders tendered 4.3 million shares (93 percent of GBL' s shares outstanding) under BLUD's cash tender offer to acquire GBL for $5.40 per share, or $25 million (see BioCentury, Sept. 28). GBL...